{
    "2021-06-28": [
        [
            {
                "time": "2023-03-15",
                "original_text": "AbbVie (ABBV) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Gains",
                        "Lags",
                        "Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of European Crohn's and Colitis Organisation (ECCO)",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Gastroenterology",
                        "Pipeline",
                        "ECCO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "AbbVie's (ABBV) Rinvoq sNDA Decision Delayed by the FDA",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rinvoq",
                        "sNDA",
                        "FDA",
                        "Delayed"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "regulatory"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval",
                "features": {
                    "keywords": [
                        "High-Dividend",
                        "Stocks",
                        "Cathie Wood",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks",
                        "investment"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}